A questionnaire-based survey of medical conditions in adults with Prader-Willi syndrome in Japan: implications for transitional care

• Published in: Endocrine Journal Vol. 70; no. 5; pp. 519 - 528
• Main Authors: Kawai, Masanobu, Muroya, Koji, Murakami, Nobuyuki, Ihara, Hiroshi, Takahashi, Yutaka, Horikawa, Reiko, Ogata, Tsutomu
• Format: Journal Article
• Language: English
• Published: Japan The Japan Endocrine Society 01-01-2023; Japan Science and Technology Agency
• Subjects: Adult; Adults; Body mass; Children; Diabetes mellitus (non-insulin dependent); Diabetes Mellitus, Type 2 - drug therapy; Female; Growth Hormone; Growth hormones; Human Growth Hormone - therapeutic use; Humans; Hypertension; Japan - epidemiology; Male; Multidisciplinary teams; Obesity; Obesity - complications; Patients; Pediatrics; Prader-Willi syndrome; Prader-Willi Syndrome - complications; Prader-Willi Syndrome - epidemiology; Prader-Willi Syndrome - therapy; Questionnaires; Surveys; Surveys and Questionnaires; Transitional Care; Type 2 diabetes mellitus; Japan; Transitional care; Obesity; Type 2 diabetes mellitus; Prader-Willi syndrome
• ISSN: 0918-8959; 1348-4540
• DOI: 10.1507/endocrj.EJ22-0561

Prader-Willi syndrome (PWS) is a multisystem disorder with increased mortality predominantly due to obesity-associated complications; therefore, the management of obesity has been centric to therapeutic strategies for PWS. Although a multidisciplinary team approach has been successful for this purpose during childhood, it is generally difficult to implement during adulthood because of the lack of a structured transitional care program. A more detailed understanding of the current medical conditions of adults with PWS is needed to establish this program; however, limited information is currently available on this issue in Japan. Accordingly, we performed a questionnaire-based survey on 425 patients with PWS. There were 162 adult patients aged 18 years or older with median body mass indexes (kg/m2) of 29.4 and 30.4 in males and females, respectively. The frequencies of type 2 diabetes mellitus (T2DM) and hypertension in adults with PWS were 40.4 and 19.4%, respectively. Growth hormone (GH) therapy during childhood correlated with lower rates of T2DM and hypertension during adulthood. Among adult patients, 54% were treated by pediatricians, whereas 44% were seen by internists with an endocrinologist/diabetologist being the most prevalent. Adult patients treated with GH during childhood showed a higher rate of being seen by pediatricians than those without, demonstrating that the multidisciplinary team approach, typically applied with GH therapy, may be continuously provided even after they reach adulthood. These results emphasize the importance of the seamless provision of the multidisciplinary team approach, which is of clinical importance for establishing an optimal transitional care program for PWS.